Histamine H2-receptor antagonists for urticaria

Cochrane Database of Systematic Reviews

Volumn 2012, Issue 3, 2012, Pages

  Fedorowicz, Zbys ^a   van Zuuren, Esther J ^b   Hu, Nianfang ^c  

^a Bahrain Branch   (Bahrain)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CIMETIDINE; DIPHENHYDRAMINE; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; RANITIDINE; HISTAMINE H1 RECEPTOR ANTAGONIST;

COMBINATION DRUG THERAPY; DISEASE DURATION; DISEASE SEVERITY; DROWSINESS; DRUG EFFICACY; DRUG SAFETY; EVIDENCE BASED MEDICINE; HUMAN; MEDICAL DECISION MAKING; MONOTHERAPY; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SAMPLE SIZE; SEDATION; SIDE EFFECT; STATISTICAL BIAS; SYSTEMATIC REVIEW; URTICARIA; DRUG COMBINATION; META ANALYSIS; METHODOLOGY;

CIMETIDINE; DIPHENHYDRAMINE; DRUG THERAPY, COMBINATION; FAMOTIDINE; HISTAMINE H1 ANTAGONISTS; HISTAMINE H2 ANTAGONISTS; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RANITIDINE; URTICARIA;

EID: 84861924163     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD008596.pub2     Document Type: Review

References (54)

1. Lin RY, Curry A, Pesola GR, Knight RJ, Lee HS, et al. Improved outcomes in patients with acute allergic syndromes who are treated with combined H1 and H2 antagonists. Annals of Emergency Medicine 2000;36(5):462-8.
2. Pontasch MJ, White LJ, Bradford JC. Oral agents in the management of urticaria: patient perception of effectiveness and level of satisfaction with treatment. Annals of Pharmacotherapy 1993;27(6):730-1.
3. Runge JW, Martinez JC, Caravati EM, Williamson SG, Hartsell SC. Histamine antagonists in the treatment of acute allergic reactions. Annals of Emergency Medicine 1992;21(3):237-42.
4. Watson NT, Weiss EL, Harter PM. Famotidine in the treatment of acute urticaria. Clinical and Experimental Dermatology 2000;25(3):186-9.
5. Blanca Gomez M, Lopez Perez-Lanzac JC. Chronic idiopathic urticaria: Double blind study with H1 plus H2 blockers [URTICARIA CRONICA IDIOPATICA: ESTUDIO A DOBLE CIEGO CON BLOQUEANTES H1 MAS H2]. Farmacia e Clinica 1984;1(7):43-6.
6. Bleehen SS, Thomas SE, Greaves MW, Newton J, Kennedy CT, et al. Cimetidine and chlorpheniramine in the treatment of chronic idiopathic urticaria: a multi-centre randomized double-blind study. British Journal of Dermatology 1987;117(1):81-8.
7. Commens CA, Greaves MW. Cimetidine in chronic idiopathic urticaria: a randomized double-blind study. British Journal of Dermatology 1978;99(6):675-9.
8. Cook J, Shuster S. Lack of effect of H2 blockade in chronic urticaria. British Journal of Dermatology 1979;101(Suppl 17):21-2.
9. Cook LJ, Shuster S. Lack of effect of cimetidine in chronic-idiopathic urticaria. Acta Dermato-Venereologica 1983;63(3):265-7.
10. Diller G, Orfanos CE. Management of idiopathic urticaria with H1 + H2 antagonists. A crossover double blind long-term study. [Article in German]. Zeitschrift fur Hautkrankheiten 1983;58(11):785-93.
11. Harvey RP, Wegs J, Schocket AL. A controlled trial of therapy in chronic urticaria. Journal of Allergy and Clinical Immunology 1981;68(4):262-6.
12. Kaur S, Greaves M, Eftekhari N. Factitious urticaria (dermographism): treatment by cimetidine and chlorpheniramine in a randomized double-blind study. British Journal of Dermatology 1981;104(2):185-90.
13. Matthews CNA, Boss JM, Warin RP, Storari F. The effect of H1 and H2 histamine antagonists on symptomatic dermographism. British Journal of Dermatology 1979;10(1):57-61.
14. Michell P, Hawk JL, Shafrir A, Corbett MF, Magnus IA. Assessing the treatment of solar urticaria. The dose-response as a quantifying approach. Dermatologica 1980;160(3):198-207.
15. Moscati RM, Moore GP. Comparison of cimetidine and diphenhydramine in the treatment of acute urticaria. Annals of Emergency Medicine 1990;19(1):12-15.
16. Paul E, Bödeker RH. Treatment of chronic urticaria with terfenadine and ranitidine. A randomized double-blind study in 45 patients. European Journal of Clinical Pharmacology 1986;31(3):277-80.
17. 2- antihistaminika ergebnisse klinischer unde experimenteller studien]. Zeitschrift fur Hautkrankheiten 1987;62(5):401-6.
18. Sharpe GR, Shuster S. In dermographic urticaria H2 receptor antagonists have a small but therapeutically irrelevant additional effect compared with H1 antagonists alone. British Journal of Dermatology 1993;129(5):575-9.
19. Simons FE, Sussman GL, Simons KJ. Effect of the H2-antagonist cimetidine on the pharmacokinetics and pharmacodynamics of the HI-antagonists hydroxyzine and cetirizine in patients with chronic urticaria. Journal of Allergy and Clinical Immunology 1995;95(3):685-93.
20. Wan KS. Efficacy of leukotriene receptor antagonist with an anti-H1 receptor antagonist for treatment of chronic idiopathic urticaria. The Journal of Dermatological Treatment 2009;20(4):194-7.
21. Wozel G, Sahre EM, Barth J. Effectiveness of combination treatment with H1-(Tavegyl) and H2-antagonists (Altramet) in chronic/chronically-recurrent urticaria. [Article in German]. Dermatologische Monatsschrift 1990;176(11):653-9.
22. Abdou AG, Elshayeb EI, Farag AG, Elnaidany NF. Helicobacter pylori infection in patients with chronic urticaria: Correlation with pathologic findings in gastric biopsies. International Journal of Dermatology 2009;48(5):464-9.
23. Baiardini I, Braido F, Bindslev-Jensen C, Bousquet PJ, Brzoza Z, Canonica GW, et al. Recommendations for assessing patient-reported outcomes and health-related quality of life in patients with urticaria: a GA(2) LEN task force position paper. Allergy 2011;66(7):840-4. [MEDLINE: PMID: 21385184]
24. Charlesworth EN. Urticaria and angioedema. Allergy and Asthma Proceedings 2002;23(5):341-5.
25. Egger M, Davey-Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315(7109):629-34.
26. Elbourne DR, Altman DG, Higgins JPT, Curtin F, Worthington HV, et al. Meta-analyses involving cross-over trials: methodological issues. International Journal of Epidemiology 2002;31(1):140-9.
27. Engin B, Uguz F, Yilmaz E, Özdemir M, Mevlitoglu I. The levels of depression, anxiety and quality of life in patients with chronic idiopathic urticaria. Journal of the European Academy of Dermatology and Venereology 2008;22(1):36-40.
28. Ferrer M. Epidemiology, healthcare, resources, use and clinical features of different types of urticaria. Alergológica 2005. Journal of Investigational Allergology and Clinical Immunology 2009;19 Suppl 2:21-6.
29. Grattan CE, Humphreys F, British Association of Dermatologists Therapy Guidelines and Audit Subcommittee. Guidelines for evaluation and management of urticaria in adults and children. British Journal of Dermatology 2007;157(6):1116-23. [MEDLINE: PMID: 18021095]
30. Greaves MW, Davies MG. Histamine receptors in human skin: indirect evidence. British Journal of Dermatology 1982;107(Suppl 23):101-5. [MEDLINE: PMID: 7138777]
31. Greaves M. Chronic urticaria. Journal of Allergy and Clinical Immunology 2000;105(4):664-72.
32. Gupta R, Sheikh A, Strachan D, Anderson HR. Increasing hospital admissions for systemic allergic disorders in England: Analysis of national admissions data. BMJ 2003;327(7424):1142-3.
33. Henderson RL, Fleischer AB, Feldman SR. Allergists and dermatologists have far more expertise in caring for patients with urticaria than other specialists. Journal of the American Academy of Dermatology 2000;43(6):1084-91.
34. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-60.
35. Higgin JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. Available from www.cochrane-handbook.org.
36. Jáuregui I, Ferrer M, Montoro J, Dávila I, Bartra J, del Cuvillo A, et al. Antihistamines in the treatment of chronic urticaria. Journal of Investigational Allergology and Clinical Immunology 2007;17(Suppl 2):41-52. [MEDLINE: PMID: 18228682]
37. Kaplan AP. Clinical practice. Chronic urticaria and angioedema. New England Journal of Medicine 2002;346(3):175-9.
38. Kaplan AP, Greaves M. Pathogenesis of chronic urticaria. Clinical and Experimental Allergy 2009;39(6):777-87. [MEDLINE: PMID: 19400905]
39. Keithley JK. Histamine H2-receptor antagonists. Nursing Clinics of North America 1991;26(2):361-73. [MEDLINE: 1675461]
40. Kozel MM, Sabroe RA. Chronic urticaria: aetiology, management and current and future treatment options. Drugs 2004;64(22):2515-36. [MEDLINE: PMID: 15516152]
41. Kulthanan K, Chiawsirikajorn Y, Jiamton S. Acute urticaria: Etiologies, clinical course and quality of life. Asian Pacific Journal of Allergy and Immunology 2008;26(1):1-9.
42. Lippert U, Artuc M, Grützkau A, Babina M, Guhl S, Haase I, et al. Human skin mast cells express H2 and H4, but not H3 receptors. Journal of Investigative Dermatology 2004;123(1):116-23. [PUBMED: 15191551]
43. Maurer M, Ortonne JP, Zuberbier T. Chronic urticaria: A patient survey on quality-of-life, treatment usage and doctor-patient relation. Allergy 2009;64(4):581-8.
44. Maurer M, Weller K, Bindslev-Jensen C, Giménez-Arnau A, Bousquet PJ, Bousquet J, et al. Unmet clinical needs in chronic spontaneous urticaria. A GA2LEN task force report. Allergy 2011;66(3):317-30. [MEDLINE: PMID: 21083565]
45. Nielsen HJ. Histamine-2 receptor antagonists as immunomodulators: New therapeutic views?. Annals of Medicine 1996;28(2):107-113.
46. Philpott H, Kette F, Hissaria P, Gillis D, Smith W. Chronic urticaria: The autoimmune paradigm. Internal Medicine Journal 2008;38(11):852-857.
47. Powell RJ, Du Toit GL, Siddique N, Leech SC, Dixon TA, Clark AT, et al. BSACI guidelines for the management of chronic urticaria and angio-oedema. Clinical and Experimental Allergy 2007;37(5):631-50. [PUBMED: PMID: 17456211]
48. The Nordic Cochrane Centre, The CochraneCollaboration. Review Manager (RevMan). 5.1. Copenhagen: The Nordic Cochrane Centre, The CochraneCollaboration, 2011.
49. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273(5):408-12.
50. Shakouri A, Compalati E, Lang DM, Khan DA. Effectiveness of Helicobacter pylori eradication in chronic urticaria: evidence-based analysis using the Grading of Recommendations Assessment, Development, and Evaluation system. Current Opinion in Allergy and Clinical Immunology 2010;10(4):362-9. [MEDLINE: PMID: 20610979]
51. Stanway AD, Cohen SN, Chen CM, Hauser C, Binney L. H1-antihistamines for chronic urticaria. Cochrane Database of Systematic Reviews 2006, Issue 3. [DOI: 10.1002/14651858.CD006137]
52. Weldon DR. Quality of life in patients with urticaria. Allergy and Asthma Proceedings 2006;27(2):96-9.
53. Zuberbier T, Asero R, Bindslev-Jensen C, Walter Canonica G, Church MK, Giménez-Arnau A, et al. EAACI/GA(2)LEN/EDF/WAO guideline: Definition, classification and diagnosis of urticaria. Allergy 2009;64(10):1417-26.
54. Zuberbier T, Asero R, Bindslev-Jensen C, Walter Canonica G, Church MK, Giménez-Arnau AM, et al. 18.EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria. Allergy 2009;64(10):1427-43. [MEDLINE: PMID: 19772513]